Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

DR. STEPHEN SOLOWAY — Lobbying — Receipts Report

LD-2 disclosure · 3rd Quarter - Report (No Activity)

DR. STEPHEN SOLOWAY

via MERKAVA STRATEGIES CORPORATION

3rd Quarter (July 1 - Sep 30) · 2023Posted Nov 14, 2023Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: DR. STEPHEN SOLOWAY
Description: Medical Professional
Location: New Jersey · United States of America

Registrant

Firm: MERKAVA STRATEGIES CORPORATION
Description: Healthcare
Location: Charleston, South Carolina, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.